Understanding how racism affects cancer pain treatment equity
A multi-level examination of the influences of racism on cancer pain equity
This study is looking at how different racial and ethnic groups of cancer patients experience pain management, especially when it comes to using opioids, and aims to find ways to improve pain relief for everyone by understanding their unique challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11041138 on NIH RePORTER |
What this research studies
This research aims to explore the racial and ethnic disparities in the management of cancer pain, particularly focusing on how these disparities affect the use of opioids among cancer patients. By analyzing data from a large population of cancer patients, the study seeks to identify the key factors contributing to inequities in pain management. The goal is to develop a multi-level intervention that addresses these disparities and improves pain treatment for affected populations. Patients will be involved in understanding their experiences and the barriers they face in receiving adequate pain relief.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients, particularly those who are Black or Hispanic, and those experiencing significant pain.
Not a fit: Patients who are not experiencing cancer pain or who do not belong to racial or ethnic minority groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable pain management practices for cancer patients of color, improving their quality of life.
How similar studies have performed: Previous studies have highlighted disparities in opioid management among cancer patients, indicating that this research builds on existing knowledge but aims to address gaps in understanding and intervention.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Enzinger, Andrea C — Dana-Farber Cancer Inst
- Study coordinator: Enzinger, Andrea C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.